Literature DB >> 20029817

A nationwide survey of hepatitis E virus infection in the general population of Japan.

Masaharu Takahashi1, Kazuko Tamura, Yu Hoshino, Shigeo Nagashima, Yasuyuki Yazaki, Hitoshi Mizuo, Sadahiko Iwamoto, Masanobu Okayama, Yoshikazu Nakamura, Eiji Kajii, Hiroaki Okamoto.   

Abstract

To investigate nationwide the prevalence of hepatitis E virus (HEV) infection in the general population of Japan, serum samples were collected from 22,027 individuals (9,686 males and 12,341 females; age, mean +/- standard deviation: 56.8 +/- 16.7 years; range: 20-108 years) who lived in 30 prefectures located in Hokkaido, mainland Honshu, Shikoku, and Kyushu of Japan and underwent health check-ups during 2002-2007, and were tested for the presence of IgG, IgM, and IgA classes of antibodies to HEV (anti-HEV) by in-house ELISA and HEV RNA by nested RT-PCR. Overall, 1,167 individuals (5.3%) were positive for anti-HEV IgG, including 753 males (7.8%) and 414 females (3.4%), the difference being statistically significant (P < 0.0001). The prevalence of anti-HEV IgG generally increased with age and was significantly higher among individuals aged >or=50 years than among those aged <50 years (6.6% vs. 2.7%, P < 0.0001). Although 13 individuals with anti-HEV IgG also had anti-HEV IgM and/or anti-HEV IgA, none of them had detectable HEV RNA. The presence of HEV RNA was further tested in 50 or 49-sample minipools of sera from the remaining 22,014 individuals, and three individuals without anti-HEV antibodies tested positive for HEV RNA. The HEV isolates obtained from the three viremic individuals segregated into genotype 3 and were closest to Japan-indigenous HEV strains. When stratified by geographic region, the prevalence of anti-HEV IgG as well as the prevalence of HEV RNA or anti-HEV IgM and/or anti-HEV IgA was significantly higher in northern Japan than in southern Japan (6.7% vs. 3.2%, P < 0.0001; 0.11% vs. 0.01%, P = 0.0056; respectively). (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20029817     DOI: 10.1002/jmv.21678

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

Review 1.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

2.  Asymptomatic acute hepatitis E in a female patient with ulcerative colitis.

Authors:  Kazuyuki Suzuki; Ichiro Kumagai; Yuichi Yoshida; Akio Miyasaka; Yasuhiro Takikawa; Ryoichi Kamiya; Kouryo Kondo; Akinobu Kato; Toshimi Chiba; Hiroaki Okamoto
Journal:  Clin J Gastroenterol       Date:  2017-03-28

3.  Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs.

Authors:  Paul Dremsek; Jürgen J Wenzel; Reimar Johne; Mario Ziller; Jörg Hofmann; Martin H Groschup; Sandra Werdermann; Ulrich Mohn; Silvia Dorn; Manfred Motz; Marc Mertens; Wolfgang Jilg; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2011-12-18       Impact factor: 3.402

4.  Codon Usage of Hepatitis E Viruses: A Comprehensive Analysis.

Authors:  Bingzhe Li; Han Wu; Ziping Miao; Linjie Hu; Lu Zhou; Yihan Lu
Journal:  Front Microbiol       Date:  2022-06-21       Impact factor: 6.064

5.  Guillain-Barré and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan.

Authors:  Jiro Fukae; Jun Tsugawa; Shinji Ouma; Tomoko Umezu; Susumu Kusunoki; Yoshio Tsuboi
Journal:  Neurol Sci       Date:  2016-07-07       Impact factor: 3.307

6.  An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection.

Authors:  Mizuki Koyama; Tomoo Yamazaki; Satoru Joshita; Akihiro Ito; Kazuyuki Ono; Takayuki Watanabe; Yuki Yamashita; Ayumi Sugiura; Mikiko Kobayashi; Yoshinori Sato; Masaharu Takahashi; Hiroaki Okamoto; Takeji Umemura
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

7.  Prevalence of Hepatitis E Virus among Adults in South-West of Iran.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Manoochehr Makvandi
Journal:  Hepat Res Treat       Date:  2015-06-23

Review 8.  Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population.

Authors:  José-Manuel Echevarría
Journal:  Scientifica (Cairo)       Date:  2014-02-10

9.  Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005-2006.

Authors:  Zhiyuan Jia; Yao Yi; Jianhua Liu; Jingyuan Cao; Yong Zhang; Ruiguang Tian; Tao Yu; Hao Wang; Xinying Wang; Qiudong Su; Wenting Zhou; Fuqiang Cui; Xiaofeng Liang; Shengli Bi
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

10.  Hepatitis E Virus (HEV) seroprevalence in the general population of the Republic of Korea in 2007-2009: a nationwide cross-sectional study.

Authors:  Youngsil Yoon; Hye Sook Jeong; Haesun Yun; Hyeokjin Lee; Yoo-Sung Hwang; Bohyun Park; Chae Jin Lee; Sangwon Lee; Ji-Yeon Hyeon
Journal:  BMC Infect Dis       Date:  2014-09-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.